We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+14.08%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$1.84B
AUM Growth
+$183M
Cap. Flow
+$14.5M
Cap. Flow %
0.79%
Top 10 Hldgs %
24.03%
Holding
217
New
10
Increased
110
Reduced
71
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 33.15%
2 Healthcare 20.69%
3 Industrials 16.11%
4 Consumer Discretionary 8.96%
5 Consumer Staples 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUTL
126
Autolus Therapeutics
AUTL
$556M
$3.09M 0.17%
100,762
+3,347
+3% +$90.4K
NXST icon
127
Nexstar Media Group
NXST
$5.87B
$3M 0.16%
36,808
-7,295
-17% -$573K
COLL icon
128
Collegium Pharmaceutical
COLL
$938M
$2.9M 0.16%
197,037
+69,577
+55% +$1.23M
TER icon
129
Teradyne
TER
$58.9B
$2.9M 0.16%
78,358
+8,844
+13% +$356K
BGC icon
130
BGC Group
BGC
$4.91B
$2.82M 0.15%
371,553
+73,324
+25% +$543K
PFIE
131
DELISTED
Profire Energy, Inc
PFIE
$2.73M 0.15%
855,743
+111,377
+15% +$354K
HDSN
132
Hudson Technologies
HDSN
$237M
$2.73M 0.15%
2,129,906
+1,094,789
+106% +$1.94M
VG
133
DELISTED
Vonage Holdings Corporation
VG
$2.65M 0.14%
187,239
-18,804
-9% -$259K
CLDR
134
DELISTED
Cloudera, Inc.
CLDR
$2.59M 0.14%
+146,545
New +$2.23M
LRMR icon
135
Larimar Therapeutics
LRMR
$442M
$2.53M 0.14%
18,062
+12,258
+211% +$1.49M
IPHI
136
DELISTED
INPHI CORPORATION
IPHI
$2.5M 0.14%
65,854
+12,909
+24% +$445K
REI icon
137
Ring Energy
REI
$344M
$2.44M 0.13%
245,728
+7,107
+3% +$85.2K
JRVR icon
138
James River Group Holdings
JRVR
$217M
$2.43M 0.13%
57,005
-35,756
-39% -$1.46M
SGMO
139
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.43M 0.13%
143,267
+1,919
+1% +$29.2K
EDIT icon
140
Editas Medicine
EDIT
$436M
$2.42M 0.13%
76,057
-1,498
-2% -$48.4K
CTSO icon
141
Cytosorbents Corp
CTSO
$23.1M
$2.42M 0.13%
+187,300
New +$2.35M
BLFS icon
142
BioLife Solutions
BLFS
$1.69B
$2.37M 0.13%
135,181
+15,907
+13% +$315K
NTLA icon
143
Intellia Therapeutics
NTLA
$1.66B
$2.36M 0.13%
82,359
-38,286
-32% -$1.11M
NEWR
144
DELISTED
New Relic, Inc.
NEWR
$2.35M 0.13%
24,972
GWR
145
DELISTED
Genesee & Wyoming Inc.
GWR
$2.34M 0.13%
25,700
-45,065
-64% -$3.91M
CCOI icon
146
Cogent Communications
CCOI
$523M
$2.32M 0.13%
41,612
-19,498
-32% -$1.04M
XERS icon
147
Xeris Biopharma Holdings
XERS
$1.45B
$2.31M 0.13%
131,145
+445
+0.3% +$9.66K
SLAB icon
148
Silicon Laboratories
SLAB
$7.22B
$2.27M 0.12%
24,758
+397
+2% +$38.8K
PFPT
149
DELISTED
Proofpoint, Inc.
PFPT
$2.24M 0.12%
21,058
-917
-4% -$107K
ZS icon
150
Zscaler
ZS
$27.6B
$2.21M 0.12%
54,217
-3,945
-7% -$159K

Similar funds

Granahan Investment Management's Q3 2018 Portfolio in Review

As of Q3 2018, Granahan Investment Management held 217 positions worth $1.84B, up 11% from $1.66B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Granahan Investment Management's Q3 2018 filing shows 10 new, 110 increased, 71 reduced and 16 closed positions. Its largest new stake was Etsy: 542,972 shares worth $27.9M. The largest sale was SodaStream International Ltd, an estimated $35.1M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q3 2018 buy was Etsy: 542,972 shares worth $27.9M.
  • Granahan Investment Management added most to Strategic Education in Q3 2018, an estimated $16.2M increase.
  • Granahan Investment Management's biggest Q3 2018 reduction was SodaStream International Ltd, cutting an estimated $35.1M.
  • Granahan Investment Management fully exited CARE.COM, INC. in Q3 2018, selling an estimated $8.96M.
  • Granahan Investment Management's ten largest holdings make up 24% of its $1.84B portfolio in Q3 2018.
  • Granahan Investment Management opened 10 new positions and closed 16 in Q3 2018.
  • Granahan Investment Management's portfolio value rose 11% quarter-over-quarter to $1.84B.

Based on Granahan Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.